TSX:HHL Holdings Information

TSX:HHL is an equity ETF with a total of 24 individual holdings. The top holdings are Merck & Co. stock at 5.78%, Amgen at 5.48%, Medtronic at 5.43%, AstraZeneca at 5.34%, and Johnson & Johnson at 5.20%.

Total Holdings

Top 10 Percentage

52.28%

Asset Class

Equity

ETF Category

Health Care

Assets

1.63B

PE Ratio

21.27

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	MRK	Merck & Co., Inc.	5.78%	721,131
2	AMGN	Amgen Inc.	5.48%	207,360
3	MDT	Medtronic plc	5.43%	673,179
4	AZN	AstraZeneca PLC	5.34%	752,310
5	JNJ	Johnson & Johnson	5.20%	328,185
6	ISRG	Intuitive Surgical, Inc.	5.03%	114,557
7	BMY	Bristol-Myers Squibb Company	5.03%	1,335,050
8	NVSN.MX	Novartis AG ADR	5.02%	502,655
9	LLY	Eli Lilly and Company	5.00%	60,788
10	REGN	Regeneron Pharmaceuticals, Inc.	4.99%	83,520
11	TMO	Thermo Fisher Scientific Inc.	4.97%	109,931
12	DHR	Danaher Corporation	4.96%	285,785
13	A	Agilent Technologies, Inc.	4.89%	416,665
14	ABT	Abbott Laboratories	4.85%	491,870
15	ELV	Elevance Health, Inc.	4.81%	185,951
16	ABBV	AbbVie Inc.	4.79%	275,006
17	SYK	Stryker Corporation	4.77%	167,904
18	BSX	Boston Scientific Corporation	4.74%	610,035
19	UNH	UnitedHealth Group Incorporated	4.50%	178,233
20	ZTS	Zoetis Inc.	4.17%	425,034
21	n/a	Harvest Canadian T Bill Etp	0.88%	321,167
22	n/a	Foreign Currency Forwards	0.22%	n/a
23	n/a	Cash And Other Net Assets And Liabilities	-0.30%	n/a
24	n/a	Written Call Options	-0.54%	n/a

As of Nov 30, 2025